Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Etoposide × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Lymphoma, Large B-Cell, Diffuse 23 Leukemia, Myeloid, Acute 19 Burkitt Lymphoma 17 Lung Neoplasms 16 Lymphoma, Non-Hodgkin 14 Lymphoma 14 Hodgkin Disease 14 Leukemia 11 Recurrence 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Mantle-Cell 9 Lymphoma, B-Cell 9 Carcinoma, Non-Small-Cell Lung 9 Medulloblastoma 8 Multiple Myeloma 7 Lymphoma, Follicular 7 Brain Neoplasms 7 Neuroblastoma 6 Neoplasms, Germ Cell and Embryonal 6 Ependymoma 6 Sarcoma, Ewing 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Neoplasms 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Myelodysplastic Syndromes 4 Lymphoma, T-Cell, Peripheral 4 Immunoblastic Lymphadenopathy 4

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡